Bristol Myers Squibb (BMY)

[north40000]

There must be a reason BMY is trading near its 52-week low. This WSJ article was of interest this morning:


http://www.wsj.com/articles/physicians-and-physicists-join-forces-to-fight-pancreatic-cancer-1474855741

I speculate that BMY has yet to find the combination therapy from other partners to raise RRRs it needs to produce increased use of either Yervoy or Opdivo that the street once thought it would achieve.